D
b PB1-F2 62 ؉ sets gave no indication of compensatory expansion. A possible explanation is that novel, as yet undetected epitopes emerge following primary exposure to the ؊NP؊PA deletion viruses. These findings have implications for both natural infections and vaccines.
Immune escape variants are a common feature of some RNA virus infections (6, 16) . Even though most such mutational change is associated with the antibody response (20, 42) , effector CD8
ϩ T cells can supply the necessary selective pressure. Individuals with subclinical human immunodeficiency virus (HIV) infection may suddenly show evidence of increased viral load following the emergence of mutants that no longer express a key peptide recognized by controlling CD8 ϩ T cells (13, 14) . Evidence of T-cell-induced in vivo variation is also found experimentally with a model of chronic neurological disease caused by mouse hepatitis virus (21) . However, even the small RNA viruses generally express a spectrum of immunogenic peptides that can be presented in the context of one or another of the four or more different major histocompatibility complex class I (MHCI) glycoproteins expressed in any healthy person or MHC heterozygous mouse (4, 17, 38) . Why is it, then, that there can be an apparent failure to compensate for the loss of an immunodominant peptide and the associated CD8
ϩ -T-cell-mediated control? The influenza A viruses vary rapidly under antibody-mediated selection pressure (24) , though they do not normally establish persistent infections in mammalian hosts. Experiments with T-cell-receptor (TCR) transgenic mice have shown that influenza virus escape variants can emerge in the face of what is essentially a monoclonal CD8
ϩ -T-cell response (26) . This may not be a common occurrence in nature, as influenza viruses can also be controlled by the humoral response in the absence of CD8
ϩ -T-cell effector function (10, 28, 31) . Even so, though neutralizing antibody would likely eliminate any escape variants selected by the cytotoxic T lymphocytes (CTLs), the internal proteins that tend to provide the peptide targets for T-cell recognition can show evidence of naturally occurring mutation (5) . Thus, it is important to understand in this scenario whether other epitopes would compensate for the mutation and function to clear the virus from the site of infection. Recent advances in technology with the influenza A viruses have made it possible to generate mutations that disable peptide binding in the groove of the MHCI glycoprotein (19) , allowing analysis of the question whether minor CD8
ϩ -T-cell responses can compensate for the loss of a major epitope.
The reverse genetics approach (18, 37) was used to generate variants of PR8 (PR, H1N1) and HK (HK, H3N2) influenza A viruses with substitutions in the nucleoprotein (NP 366-374 , ASNENMETM) and acid polymerase (PA [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] , SSLENFRA YV) peptides that bind the H2D b MHCI glycoprotein (3, 32) . These mutations resulted in the replacement of the asparagine at the fifth position of both epitopes with glutamine (N5Q). Viruses were thus generated with single mutations in NP or PA and double mutations in NP and PA. These PR and HK mutants (ϪNP, ϪPA, and ϪNPϪPA) grow both in tissue culture and in C57BL/6J (B6) mouse lung at titers comparable to those found following infection with the wild-type (WT) viruses, though they are much more likely to cause fatal infection in antibody-negative MT mice (37 This experimental approach (37) has now been extended to look further at possible compensation by CD8 ϩ T cells specific for other known, minor epitopes (8, 36) , following secondary challenge. The consequences of primary infection are presented for the first time, and the possibility that an initial exposure to these deletion viruses modifies the response profile following WT challenge is investigated. In addition, the question is asked whether the quality of the CD8 ϩ -T-cell response to minor epitopes changes in the absence of the immunodominant effector populations.
MATERIALS AND METHODS
Mice, viruses, and infection. Female B6 mice were purchased from the Jackson Laboratory (Bar Harbor, Maine), and CD4
ϩ -T-cell-deficient MHC class II Ϫ/Ϫ mice (15) were bred at St. Jude Children's Research Hospital. All were held under specific-pathogen-free conditions at St. Jude Children's Research Hospital, and the B6 mice were first infected at 8 to 10 weeks of age. The generation and preparation of WT PR and mutant (PRϪNP, PRϪPA, and PRϪNPϪPA) recombinant viruses from the A/Puerto Rico/8/34 plasmids by using the eight-plasmid reverse genetics system and the subsequent replacement of the H1N1 PR8 hemagglutinin (H) and neuraminidase (N) plasmids (WT HK, HKϪNP, HKϪPA, and HKϪNPϪPA) with those from the H3N2 A/Aichi/2/68 (HK) virus have been described previously (18, 37) . Primed (PR variants i.p. at 10 8 50% egg infective doses [EID 50 ]) and naïve mice were first anesthetized by i.p. injection of 2,2,2-tribromoethanol (Avertin) and then infected i.n. with 10 7 EID 50 of the HK viruses (1). The mice were anesthetized again at time of sampling and then exsanguinated by section of the axillary artery. The spleens were removed, and inflammatory cell populations were recovered from the infected respiratory tract by bronchoalveolar lavage (BAL).
Flow cytometry, tetramer staining, and peptide stimulation. Virus-specific CD8
ϩ -T-cell responses were analyzed by flow cytometry (11) . Lymphocytes from disrupted spleens or mediastinal lymph nodes (MLN) were enriched for CD8 ϩ T cells by incubation with monoclonal antibodies to CD4 (GK1.5) and MHC class II glycoprotein (M5/114.15.2), followed by anti-rat and anti-mouse immunoglobulin G-coated magnetic beads (Dynal A.S., Oslo, Norway). This routinely gave a Ͼ90% depletion of CD4 ϩ -T-cell numbers when measured with a noncross-reactive monoclonal antibody (RM4-4) to CD4. Inflammatory cell populations recovered from the pneumonic lung by BAL were depleted of macrophages by incubation on plastic for 1 h at 37°C. (4, 36) . Lymphocytes were incubated for 60 min at room temperature with the phycoerythrin-conjugated tetramers in phosphate-buffered saline-bovine serum albumin-azide followed by anti-CD8␣-PerCP Cy5.5 (PharMingen, San Diego, Calif.). Other CD8 ELISPOT analysis. The ELISPOT protocol was used to estimate the total size of IFN-␥-producing CD8
ϩ -T-cell populations in spleen following stimulation with virus-infected antigen-presenting cells (APCs). Plates were coated overnight with 10 g of purified anti-IFN-␥ antibody (BD Biosciences)/ml and then washed four times and blocked for at least 30 min at 37°C with 200 l of complete medium. Serial dilutions of purified, splenic CD8 ϩ T cells from virus-infected B6 mice were then plated with APCs generated by suspending (for 1 h at 37°C) naïve spleen cells from naïve, uninfected B6 or MHC class II Ϫ/Ϫ mice in 1 ml of allantoic fluid from wtHKx31RG virus-infected hen eggs, followed by incubation for a further 3 h at 37°C after the addition of 10 ml of complete medium. Cell numbers were adjusted to plate 5 ϫ 10 5 stimulator cells/well. The plates were washed thoroughly after 48 h of incubation, biotin-conjugated anti-IFN-␥ antibody was added at a concentration of 5 g/ml, and the reaction mixture was incubated overnight. Streptavidin-alkaline phosphatase conjugate (Dako) was then added at a dilution of 1:500 in 100 l for 1 h, washed, and developed with a 5-bromo-4-chloro-3-indolylphosphate-nitroblue tetrazolium (BCIP-NBT) solution until spots were visible. The plates were washed again, dried, and counted on a Zeiss ELISPOT reader.
Data set and statistical analysis. Many of the data are expressed as virusspecific CD8
ϩ -T-cell numbers, which were calculated from the percentage of cells staining with tetrameric reagents or IFN-␥ (PepC assay) and the percentage of CD8␣
ϩ and the total cell counts for the enriched spleen, MLN, or BAL sample populations that were analyzed by flow cytometry. The results are generally for groups of five mice. The findings for those infected with the mutant (ϪNP, ϪPA, and ϪNPϪPA) viruses were compared (generally by Student's t test) with the numbers generated following exposure to WT virus. Significant differences, P Յ 0.05, are identified by an asterisk in the figures.
RESULTS
The basic aim of these experiments was to determine whether the increase in numbers that we saw previously (37) for the CD8 ϩ set in spleen, BAL sample, and MLN populations analyzed on day 7 at the peak of the secondary response (Fig. 1C, F , and I). This increase in CD8 ϩ K b PB1 703 ϩ -T-cell numbers was still apparent in the spleen on day 10 and day 30, though not in the BAL sample or the MLN. The inflammatory process in the BAL sample cells begins to resolve by day 10, while activated-mem-ory CD8
ϩ T cells present on day 10 and the few remaining cells on day 30 are likely to have down-regulated expression of the CD62L lymph node homing receptor and will thus tend to be found in the spleen, where CD62L does not play a part in lymphocyte localization (33) . There was also a persistent increase in the numbers of splenic CD8 ϩ D b PA 224 ϩ T cells in the mice that were given the PRϪNP and HKϪNP viruses (Fig. 1B and E) . This means that, because the spleen contains a very high proportion of the peripheral CD8
ϩ -T-cell pool, the size of both the CD8
PA 224 ϩ memory populations is substantially increased (Fig. 1B and C) over the values found in the WT HK3PR mice. By contrast, no significant change in magnitude was found at any time point for the immunodominant CD8
ϩ D b NP 366 ϩ set in the HKϪPA3 PRϪPA challenge group (Fig. 1A , D, and G).
This analysis of CD8 ϩ K b PB1 703 ϩ -T-cell prevalence by tetramer staining (Fig. 1 Table 1 ).
The spleen response to K b M1 128 was minimal throughout and was not significantly increased (over the WT HK3PR challenge) for the mutant viruses (days 7 to 30, Table 1 ). However, though stimulation with the NS2 114-121 peptide tended to elicit relatively small numbers of CD8 ϩ T cells in mice primed and boosted with the WT viruses, the K b NS2 114 -specific sets found at all time points for the HKϪNPϪPA3PRϪNPϪPA challenge were at least comparable in size to the K b PB1 703 -specific populations (Table 1) . Furthermore, even in the WT HK3PR mice, substantial numbers of memory K b NS2 114 -specific T cells were found on day 30 ( Table 1) .
The same was true when we looked at the K b NS2 114 -and K b PB1 703 -specific sets in the day 7 BAL sample populations ( Fig. 2A and B ). Both were consistently and substantially increased in number for the mice given the mutant viruses. The profile for K b M1 128 was similar, but the T-cell numbers were 5 to 10 times lower than those found for the other epitopes, and the counts were also more variable (Fig. 2C) . The decision was thus taken not to pursue the K b M1 128 analysis further, though we did proceed to make the K b NS2 114 tetramer. In a further experiment, tetramer analysis of the secondary response to K b NS2 114 on day 10 after priming and challenge with the mutant and WT viruses (Fig. 3) confirmed what was seen previously with the IFN-␥ study (Table 1; Fig. 2 ). Overall, there seems to be a good measure of compensation by the expansion of other epitope-specific CD8
ϩ -T-cell populations in the secondary HKϪNPϪPA3PRϪNPϪPA response.
Reversing the prime-boost conditions. The experimental protocol was then varied by first giving the HK viruses i.n., followed 30 days later by i.p. challenge with a high dose of the PR viruses (Table 2) . Changing from PR i.p.3HK i.n. to HK i.n.3PR i.p. reversed the sequence of lytic and nonlytic infection in this prime-boost strategy. Though there is substantial replication of the virus in the lung and upper airways following i.n. challenge, virus given i.p. is thought to induce only a single cycle of protein synthesis with little (if any) virus production and consequent infection of other cells. The difference reflects the fact that cleavage of the influenza virus hemagglutinin to make mature virus requires the involvement of a protease that is restricted in distribution to the respiratory epithelium (22, 40) . This change in regimen would thus limit the availability of the antigen in the secondary challenge with the PR viruses. Again, the response to K b M1 128 was minimal, while the responses to K b PB1 703 and K b NS2 114 were significantly enhanced in the mice given the mutant viruses (Table 2) .
Primary response. The experiments so far (37) ( Tables 1  and 2 ; Fig. 1 to 3 ) focused on the recall of virus-specific CD8
ϩ -T-cell memory, without presenting a systematic analysis of what happens after primary i.n. exposure to the WT HK, HKϪNP, HKϪPA, and HKϪNPϪPA viruses. Unlike the situation following secondary challenge ( Fig. 1 to 3 Fig. 4A to D) . This was also true for the BAL sample cells on day 10 (Fig. 4E) . The compensatory effect ( Fig. 1 to 3 ; Table 1) found for the recall response following i.n. challenge with the homologous, mutant HK and PR viruses was thus not seen for these individual epitope-specific sets following primary infection (Fig. 4) .
Challenge with WT virus. The question was then asked whether priming with the mutant viruses in any way modifies the response following a WT challenge, a situation that would occur following natural infection if such viruses were being used in a vaccination strategy. Mice were first exposed i.p. to the panel of PR viruses. All were later infected i.n. with WT HK virus. In general, the CD8 ϩ K b PB1 703 ϩ response in the WT HK-infected mice that had been primed with the PRϪNP, PRϪPA, and PRϪNPϪPA viruses was not significantly increased over that found for the WT HK3PR group (Table 3) . This is in accord with the observation that priming with the mutant viruses does not either increase the magnitude of the primary response (Fig. 4) or result in persistent memory (day 0, Fig. 1 Table 3 and Fig. 4) , suggesting that secondary responses to both major and minor epitopes can diminish the magnitude of a concurrent primary response.
Quality of the compensatory secondary response. The analysis of quality is based on the cytokine expression profiles following short-term peptide stimulation (23, 29). The two 7 EID 50 per mouse. Spleens were harvested on days 0 (8 weeks after priming), 7, 10, and 30, and the IFN-␥ ϩ assay was performed as described in Materials and Methods. The significant differences from the WT are indicated as * (P Ͻ 0.05).
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measures were the percent TNF-␣ ϩ cells within the CD8 ϩ IFN-␥ ϩ cell set (Fig. 5 ) and the intensity of IFN-␥ (Fig. 6A to D) and TNF-␣ (Fig. 6E to H ) staining determined as mean fluorescence intensity (MFI). The MFI value can be considered to reflect the magnitude of peptide-induced cytokine production. The great majority of the K b NS2 114 -and K b PB1 703 -specific CD8
ϩ IFN-␥ ϩ T cells recovered from the spleen and BAL fluid compartments of secondarily challenged mice were found to produce TNF-␣ (Fig. 5) . This profile was not substantially modified for the mutant viruses, though it was consistently the case that the prevalence of TNF-␣ ϩ cells in spleen (Fig. 5A and C) was at maximum frequency on day 30, in accord with previous observations on the maturation of "functional avidity" with time (23, 30) . The values for the BAL cells recovered from the respiratory tract, the site of high antigen load in this influenza model, were always close to maximum frequency (Fig. 5C and D) .
The intensity of MFI staining was significantly higher for spleen cells recovered on day 7 from mice given some of the deletion viruses (day 7, Fig. 6A and B) , but the effects were not large and were not mirrored by the profiles for TNF-␣ (day 7, Fig. 6E and F) . The MFI values for TNF-␣ (but not IFN-␥) then fell substantially on day 10 (day 10, Fig. 6 ; compare panels E and F and panels A and B), which could reflect that TNF-␣ high cells are being recruited to the virus-infected lung. The intensity of staining was more than restored by day 30 (Fig. 6E  and F) , though the CD8 ϩ K b PB1 703 ϩ memory T cells from mice given the mutants were consistently making less cytokine than those induced by the prime-boost with the WT viruses 
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(day 30, Fig. 6A and E). However, the same effect was not seen for the CD8 ϩ K b NS2 114 set (day 30, Fig. 6B and F) . The most striking finding for the inflammatory CD8 ϩ T cells recovered by BAL was that the intensity of both IFN-␥ and TNF-␣ staining on day 7 was greatest in the mice given the HKϪPA3PRϪPA challenge (day 7, Fig. 6C, D, G, and H) , while the highest levels of both cytokines for CD8
T cells recovered from the resolving response on day 10 were found for the mice given the mutant NP viruses (day 10, Fig. 6 ; compare panels C and G and panels D and H). Overall, there was no substantial change in the quality of the acute response or memory for these minor T-cell populations expanded in the absence of the major subsets.
Extent of compensation in primary and secondary responses. The findings from the tetramer and IFN-␥ PepC assays indicated that the size of the residual epitope-specific CD8 ϩ -T-cell populations increased following secondary (Tables 1 and 2; Fig. 1 to 3 ), but not primary (Fig. 4) , challenge with the ϪNPϪPA viruses. The data presented in part in Table  1 and Fig. 2 were thus used to estimate the total size of the secondary CD8
ϩ -T-cell response (Fig. 7) , the aim being to determine the overall extent of compensation while at the same time addressing the possibility that T cells specific for some other, substantial epitope are not being measured. The total CD8
ϩ -T-cell counts in the HKϪNPϪPA3PRϪNPϪPA group were significantly increased for day 7 in the spleen and BAL sample (Fig. 7A and B) , while the opposite effect was seen for the relative prevalence (percentages) of virus-specific cells in the day 7 and day 10 BAL sample populations (Fig.  7D) . Overall, it seemed that the compensation effect in the secondary response was partial.
It is, however, also possible that other minor epitopes (41) are being expanded in the HKϪNPϪPA3PRϪNPϪPA response. ELISPOT analysis after stimulation with virus-infected cells was thus used to estimate the total size of both primary (HK viruses i.n.) and secondary (PR viruses i.p. and then HK viruses i.n.) virus-specific CD8
ϩ -T-cell responses in spleen (Fig. 8) . Though ELISPOT analysis with virus-infected APCs is generally less sensitive than the flow-cytometric PepC assays, the results indicated that the level of both primary (Fig. 8A) and secondary (Fig. 8B ) response made by CD4-depleted virus-immune spleen cells following stimulation with HK-infected stimulators was no different for the WT RG and ϪNPϪPA viruses. This was also true when MHC class II Ϫ/Ϫ APCs were used to obviate any possibility that the result was confounded by residual CD4
ϩ -T-cell responders, though the level of stimulation was somewhat lower, reflecting, perhaps, that dendritic cells from CD4
ϩ -T-cell-deficient mice do not
FIG. 4. Characteristics of the primary virus-specific CD8
ϩ -T-cell response. The B6 mice were infected i.n. with 10 7 EID 50 of the HK variants. The spleen (A to D) and BAL fluid (E) populations were sampled on day 10 at the peak of the acute response, and the early phase of memory was measured on day 30 (A to D) for the spleen. The numbers of tetramer ϩ CD8 ϩ T cells were calculated from total cell counts and the percentages of cells staining. The results are expressed as means Ϯ standard deviations, and significant differences from the HK-WT values are indicated by an asterisk (P Յ 0.05).
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function optimally due to lack of "background conditioning" (27) by other helper T-cell responses. The ELISPOT results (Fig. 8) thus suggest that other epitopes may be emphasized in, particularly, the primary response to these mutant viruses. We had not been using the PB1-F2 62-70 (8) peptide because earlier experiments (unpublished data) had indicated that the primary response to this H2D b -restricted epitope is minimal. Analysis for the D b PB1 62 -specific set indicated that the sizes of the CD8 ϩ PB1-F2 62 ϩ sets in spleen (Fig. 9A ) and BAL fluid (Fig. 9B) were not increased following primary i.n. challenge with the HKϪNPϪPA virus. However, the secondary response to D b PB1 62 was substantial
ϩ T cells in a secondary response. The mice were primed and challenged as described in the legend to Fig. 1 . The levels of TNF-␣ ϩ and IFN-␥ ϩ production were determined by intracellular cytokine staining subsequent to peptide stimulation (see legend to Fig. 2) , and the IFN-␥ ϩ TNF-␣ ϩ /IFN-␥ ϩ ratios were determined for the BAL fluid and spleen populations. The results are expressed as means Ϯ standard deviations, and significant differences from the findings for the WT group are indicated by an asterisk (P Յ 0.05). 
a B6 mice mice were primed i.p. with 10 8 EID 50 of the PR WT and mutant (ϪNP, ϪPA, and ϪNPϪPA) viruses and then challenged i.n. with 10 7 EID 50 of the WT HKx31 virus. The spleen and BAL fluid populations were harvested on day 9 (experiment 1) or day 8 (experiment 2). The mice in experiment 1 were challenged 2 months after priming, while those in experiment 2 were left for 7 months prior to challenge. The numbers in parentheses indicate the type of response generated for each virus-specific epitope following the WT virus challenge. The numbers of tetramer CD8 ϩ T cells were calculated from the percentages of cells staining and the total cell counts. Significant differences from the WT values are indicated as * (P Ͻ 0.05).
VOL. 79, 2005
MINOR VIRUS-SPECIFIC CD8 ϩ -T-CELL RESPONSES 4335
( Fig. 9C and D) , indicating that this could explain the apparent difference for the estimates of total size by the PepC (Fig. 7) and ELISPOT (Fig. 8) assays. This apparent compensation in the primary response (Fig. 8A) following i.n. challenge with the HKϪNPϪPA virus is not, however, resolved by this analysis with D b PB1 62 (Fig. 9A and B) . One possibility is that other, previously disregarded peptides may be involved following primary exposure (41) . Future experiments will test the idea that the range of a primary response can be expanded in the absence of prominent epitopes.
DISCUSSION
The absence of any obvious change in "quality" for the enlarged CD8 Even so, the CD8 ϩ K b PB1 703 ϩ memory T cells sampled on day 30 from the mice given the mutant viruses were making less IFN-␥ and TNF-␣ than those from the WT prime-boost, reversing the situation found for the day 10 BAL sample population specific for the same epitope. The change between the acute response and memory is, however, unlikely to reflect some TNF-␣-mediated editing process, which has been shown in previous experiments to operate only for the relatively small numbers of T cells that have localized to the site of virus-induced pathology (and high antigen load) in the infected lung (34, 39) . Also, this divergence in cytokine production for CD8 The overall conclusion from these experiments, and the less extensive previous study (37) , is that each epitope-specific CD8 ϩ -T-cell population has inherent characteristics that can be varied only within certain limits. However, it is possible to push responses to a higher level, at least in terms of the extent of clonal expansion (12) and eventual numbers, such that residual T-cell sets can compensate fully for the loss of major epitopes, at least following secondary challenge. There are situations where it might be deemed advantageous to enhance the potential for a particular CD8
ϩ -T-cell response. What may normally be a minor epitope on the surface of a virus-infected (or tumor) cell (2) may, in fact, be a particularly useful target for T-cell-mediated elimination. The question of what determines these immunodominance hierarchies needs to be answered.
One possibility is that immunodominance may be a function of the avidity of the interaction between the clonotypic TCRs and antigenic peptide-MHCI complexes (23) . If so, the rela- PA 224 -specific responses are equivalent in size following primary infection, but in excess of 10-fold-more CD8 ϩ D b NP 366 ϩ T cells are generated following secondary challenge (25) . This could in part reflect that the D b PA 224 epitope seems to be expressed mainly on dendritic cells (DCs), while D b NP 366 is found on a variety of cell types including DCs and infected epithelium (9) . Current experiments are looking at the possibility that relocating the PA 224-233 peptide to the influenza virus neuraminidase stalk (7) will change the profile of antigen expression, the quality of the responding CD8 ϩ -T-cell populations following influenza virus infection of previously unexposed mice. Prior evidence suggests that the induction of primary CD8
ϩ -T-cell responses is totally dependent on the binding of naïve precursors to antigen-presenting DCs over a relative short time (35) . Any primary response may thus be considered to reflect the spectrum of epitope availability on the DCs and, perhaps, the size of the potential TCR responder repertoire. The fact that these minor responses increased in magnitude following secondary challenge with mutant viruses presumably reflects that the more readily triggered memory T cells are responding to prolonged epitope expression on DCs (and other cell types) as a consequence of delayed elimination in the absence of the normally immunodominant effector Tcell populations. Again, the interplay among antigen concentration, antigen availability, TCR repertoire constraints, and TCR epitope avidity presumably determines the ultimate magnitude of the secondary response. It is worth establishing the relative importance of these different components as we try to develop CD8
ϩ -T-cell-peptide-based vaccines to counter infectious and, perhaps, oncogenic processes. The present experiments define some of the baselines for moving such analyses forward.
